Severe Infection Outcomes With SGLT2 Versus DPP‐4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active‐Comparator Meta‐Analysis of Real‐World Cohorts
Yung‐Ming Huang, Jen‐Hung Wang, Wan‐Ting Huang, Ji‐Ze Hsu, Soon‐Hian Teh. Severe Infection Outcomes With SGLT2 Versus DPP‐4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active‐Comparator Meta‐Analysis of Real‐World Cohorts. // Endocrinology, Diabetes and Metabolism. – 2026. – DOI: 10.1002/edm2.70381. – URL: https://onlinelibrary.wiley.com/doi/10.1002/edm2.70381?af=R
Yung‐Ming Huang, Jen‐Hung Wang, Wan‐Ting Huang, Ji‐Ze Hsu, & Soon‐Hian Teh (2026). Severe Infection Outcomes With SGLT2 Versus DPP‐4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active‐Comparator Meta‐Analysis of Real‐World Cohorts. Endocrinology, Diabetes and Metabolism. https://doi.org/10.1002/edm2.70381
Yung‐Ming Huang, et al. “Severe Infection Outcomes With SGLT2 Versus DPP‐4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active‐Comparator Meta‐Analysis of Real‐World Cohorts.” Endocrinology, Diabetes and Metabolism, 2026. doi:10.1002/edm2.70381.
@article{Huang2026,
title = {Severe Infection Outcomes With SGLT2 Versus DPP‐4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active‐Comparator Meta‐Analysis of Real‐World Cohorts},
author = {Huang, Yung‐Ming and Wang, Jen‐Hung and Huang, Wan‐Ting and Hsu, Ji‐Ze and Teh, Soon‐Hian},
journal = {Endocrinology, Diabetes and Metabolism},
year = {2026},
doi = {10.1002/edm2.70381},
url = {https://onlinelibrary.wiley.com/doi/10.1002/edm2.70381?af=R}
}